Literature DB >> 28360735

Neurological Complications after Renal Transplantation: A Retrospective Clinical Study.

Nilgün Cengiz1, Zelal Adibelli2, Yarkın Kamil Yakupoğlu3, Hande Türker1.   

Abstract

INTRODUCTION: The aim of this study was to evaluate the incidence and types of neurological complications (NCs) and associated factors in renal transplantation (RT) patients.
METHODS: Three hundred and forty-four patients who had RT performed at our institution between January 2005 and July 2014 were retrospectively evaluated.
RESULTS: File records of the patients revealed 19 who experienced a total of 22 episodes of NCs, of whom three had more than one episode. The mean age of 19 patients included in the study, of whom eight were female, was 37.52±13.08 (range, 18-65) years. NCs were classified into central or peripheral depending on the location of involvement of the central nervous system (CNS). CNS involvement was found in 16 (84.2%) of the 19 patients. Tremor (36.8%) was the most common CNS complication in these patients. Encephalopathy, generalized tonic-clonic seizures, and status epilepticus were observed in two patients (10.5%). Delirium and dementia were observed in one patient (5.2%). Headache was experienced by one patient, and agitated depression was observed in one patient. Six patients (26.3%) had the peripheral nervous system involvement. One patient had the numbness of hands with normal electromyography findings, and four patients had polyneuropathy. In one patient, lumbar plexopathy was observed. Seventeen of the 22 NCs were considered to be caused by immunosuppressive agents. Each incidence of amyloidosis, infection, septic emboli, and hypoglycemia caused a neurological episode. The etiology of one episode was unknown.
CONCLUSION: Different neurological disorders can be seen after RT, and most of them are caused by immunosuppressive drugs. NCs seen after RT can be treated by decreasing the dose or changing the immunosuppressive drug.

Entities:  

Keywords:  Encephalopathy; neurological complications; renal failure; renal transplantation

Year:  2015        PMID: 28360735      PMCID: PMC5353103          DOI: 10.5152/npa.2015.9876

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  29 in total

1.  Treatment of Guillain-Barré syndrome induced by cyclosporine in a lung transplant patient.

Authors:  Jeremy A Falk; Francis C Cordova; Anca Popescu; Gabriel Tatarian; Gerard J Criner
Journal:  J Heart Lung Transplant       Date:  2005-11-14       Impact factor: 10.247

Review 2.  Neurological complications in kidney transplant recipients.

Authors:  Claudio Ponticelli; Maria Rosaria Campise
Journal:  J Nephrol       Date:  2005 Sep-Oct       Impact factor: 3.902

3.  Posterior reversible encephalopathy syndrome (PRES): electroencephalographic findings and seizure patterns.

Authors:  Oliver Kastrup; Markus Gerwig; Markus Frings; Hans-Christoph Diener
Journal:  J Neurol       Date:  2011-12-22       Impact factor: 4.849

4.  Femoral neuropathy in renal transplantation.

Authors:  I Junaid; J T Kwan; R H Lord
Journal:  Transplantation       Date:  1993-07       Impact factor: 4.939

5.  Electrophysiologic changes in uremic neuropathy after successful renal transplantation.

Authors:  C F Bolton
Journal:  Neurology       Date:  1976-02       Impact factor: 9.910

6.  Neurologic complications of renal transplant.

Authors:  Pinar Ce; Asli Koskderelioglu; Gokmen Coban; Muhtesem Gedizlioglu; Ahmet Nart; Adam Uslu
Journal:  Exp Clin Transplant       Date:  2012-06       Impact factor: 0.945

Review 7.  Clinical aspects of the MDR1 (ABCB1) gene polymorphism.

Authors:  Michel Eichelbaum; Martin F Fromm; Matthias Schwab
Journal:  Ther Drug Monit       Date:  2004-04       Impact factor: 3.681

8.  Neurotoxicity induced by tacrolimus after liver transplantation: relation to genetic polymorphisms of the ABCB1 (MDR1) gene.

Authors:  Atsushi Yamauchi; Ichiro Ieiri; Yasufumi Kataoka; Mizuho Tanabe; Takashi Nishizaki; Ryozo Oishi; Shun Higuchi; Kenji Otsubo; Keizo Sugimachi
Journal:  Transplantation       Date:  2002-08-27       Impact factor: 4.939

9.  Influence of CYP3A5 and ABCB1 gene polymorphisms on calcineurin inhibitor-related neurotoxicity after hematopoietic stem cell transplantation.

Authors:  Masakatsu Yanagimachi; Takuya Naruto; Reo Tanoshima; Hiromi Kato; Tomoko Yokosuka; Ryosuke Kajiwara; Hisaki Fujii; Fumiko Tanaka; Hiroaki Goto; Tatsuhiko Yagihashi; Kenjiro Kosaki; Shumpei Yokota
Journal:  Clin Transplant       Date:  2010 Nov-Dec       Impact factor: 2.863

10.  Progressive neurological disease induced by tacrolimus in a renal transplant recipient: case presentation.

Authors:  Marjan Chegounchi; Michael G Hanna; Guy H Neild
Journal:  BMC Nephrol       Date:  2006-03-31       Impact factor: 2.388

View more
  2 in total

Review 1.  An Approach to Neurological Disorders in a Kidney Transplant Recipient.

Authors:  Priti Meena; Vinant Bhargava; Devinder Rana; Anil Bhalla; Ashwani Gupta
Journal:  Kidney360       Date:  2020-06-16

2.  The Prevalence of Neurological Complication after Renal Transplantation.

Authors:  Xiaorong Zhu; Liangrong Shen; Dan Li; Luoning Shi; Qing Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-04       Impact factor: 2.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.